With a continued industry focus on the safe handling of highly potent compounds, online training and webinars are an affordable and convenient way to achieve occupational safety training goals.
Broomfield, CO (PRWEB) January 09, 2012
Affygility Solutions is pleased to announce the release its 2012 occupational health and safety course schedule. "In response to customer demand, Affygility Solutions has expanded its occupational health and safety webinar offering for 2012," states Dean Calhoun, CIH, President and CEO of Affygility Solutions. "In addition to our popular Advanced Topics in Potent Compound Safety series, we are excited to now offer a new health and safety course on Manufacturing Category 4 or 5 Potent Compounds - Understanding and Controlling the Risks. With a continued industry focus on the safe handling of highly potent compounds, online training and webinars are an affordable and convenient way to achieve occupational safety training goals. Affygility Solutions' webinars help our clients meet these goals."
Affygility Solutions' expanded health and safety course schedule now includes webinars on potent compound safety, dermal exposure and absorption of active pharmaceutical ingredients, isoflurane safety, laboratory safety, global harmonization system, methylene chloride safety, hazardous wastes generators training for hospitals, clinics, and medical laboratories, and more.
Since 2007, the environmental, health and safety, and technology experts at Affygility Solutions have conducted health and safety courses and webinars that have been attended by hundreds of professionals in the biotechnology, pharmaceutical, and medical device industry. Affygility Solutions' health and safety webinars are taught using the latest in webinar technology that allows participant interaction and immediate feedback.
For a complete listing of Affygility Solutions' 2012 health and safety course offerings and other company information, go to: http://affygility.com
About Affygility Solutions
Affygility Solutions offers environmental, industrial hygiene, safety and occupational toxicology services to the biotechnology, pharmaceutical and medical device industries. The services include its environmental, health and safety software, exposure assessments for active pharmaceutical ingredients, containment validation and surrogate monitoring studies, the establishment of occupational exposure limits, and much more. These services have been performed for small to large companies throughout the United States, Europe, India, and Asia.